Shortlist for WMAHSN's Celebration of Innovation Awards announced

Posted on 13 July 2017 (Permalink)

The shortlist has now been released for WMAHSN's Celebration of Innovation Awards 2017! 

Following the success of last year's awards - which saw more than 80 entries flood in from across the West Midlands - this year, there are even more categories, celebrating innovation in healthcare across the region. 

The awards will be presented at a glitzy ceremony at the WMAHSN's Celebration of Innovation Event on 20 July - you can take a look at the programme - and reflect the WMAHSN's dual aim of improving health and creating wealth, as well as the organisation's key priorities and themes. There are also special awards for innovative individuals or teams and innovative organisations.

The shortlisted organisations are: 

Innovative Organisation Award

Innovative Team of the Year Award

Economic Impact Award

Excellence in Wellness and Prevention of Illness Award

MidTECH Award for Best NHS Invention or Innovation

Patient Safety Award

Supporting Self Care Innovation Award

Social Enterprise Award

Medicines Optimisation Award

Mental Health Innovation Award

Industry Collaboration Award

Advanced Diagnostics, Genomics and Precision Medicine Award

You can take a look at the full list of awards criteria here

Tammy Holmes, Innovation and Adoption Programme Manager at WMAHSN, said: "We were absolutely delighted with the response to our first ever Celebration of Innovation Awards last year, and this year's awards have already proven to be bigger and better, with 107 entries across the 12 categories.  

"As an AHSN, we work with innovators from across the healthcare sector, whether industry, NHS, academia, social enterprise or the third sector. These awards acknowledge the hard work going on throughout the West Midlands across the gamut of life sciences, and reward contributions towards our overall aim of accelerating the adoption of innovation to generate continuous improvement in the region’s health and wealth."

Dr Christopher Parker, Managing Director of WMAHSN, said: "While it was a very difficult task to whittle down the entries, our shortlisted entries all show proof of a collaborative approach to identifying the problem and developing the innovation, and clear evidence that the innovation has been implemented effectively. Importantly, they have shown evidence of the impact of the innovation on patient outcomes and value for money, and are demonstrably scalable, whether across the UK, Europe or even internationally.

"I would like to thank everyone for entering, and the very best of luck to our worthy shortlisted entrants!"